The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKerry Regulatory News (KYGA)

Share Price Information for Kerry (KYGA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.90
Bid: 77.50
Ask: 78.00
Change: 1.10 (1.43%)
Spread: 0.50 (0.645%)
Open: 77.70
High: 78.10
Low: 77.40
Prev. Close: 76.80
KYGA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kerry to acquire Lactase Enzymes Business

12 Dec 2023 16:13

RNS Number : 5363W
Kerry Group PLC
12 December 2023

12 December 2023

LEI: 635400TLVVBNXLFHWC59

KERRY GROUP

Kerry to acquire Lactase Enzymes Business

Kerry Group plc ("Kerry"), the global taste & nutrition company, announces it has entered into a definitive agreement to acquire part of the global lactase enzyme business of Chr. Hansen Holding A/S ("Chr. Hansen") and Novozymes A/S ("Novozymes") (together the "Lactase Enzymes Business") on a carve out basis¹. This acquisition is subject to European Commission approval of Kerry as a buyer and forms part of the Novozymes and Chr. Hansen merger approval process.

The Lactase Enzymes Business which includes NOLA® Products, further enhances Kerry's biotechnology solutions capability following the acquisitions of c-LEcta and Enmex². This acquisition adds enzyme technology which helps create lactose-free and sugar reduced dairy products, while preserving their authentic clean taste. Global demand for lactase is being driven by increased awareness of lactose intolerance, while many consumers are also choosing lactose-free for lifestyle and health reasons.

The Lactase Enzymes Business had attributable revenue of approximately ?40m in 2022 with sales in over 50 countries. Total consideration is ?150m subject to routine closing adjustments, with the acquisition expected to close in the first half of 2024.

¹ Acquisition comprises certain trade and assets of Chr. Hansen's global lactase enzyme business and 100% of the share capital of Nuocheng Trillion Food (Tianjin) Co., Ltd, a Chinese subsidiary of Novozymes.

² Acquisition of c-LEcta GmbH completed in March 2022 and Enmex S.A. de C.V. in December 2021.

ENDS

About Kerry

Kerry is a world leading taste and nutrition partner for the food, beverage and pharmaceutical markets. We innovate with our customers to create great tasting products, with improved nutrition and functionality, while ensuring better impact for the planet. Our leading consumer insights, global RD&A team of 1,100+ food scientists and extensive global footprint enable us to solve our customers' complex challenges with differentiated solutions. At Kerry, we are driven to be our customers' most valued partner, creating a world of sustainable nutrition, and to reach over 2 billion consumers with sustainable nutrition solutions by 2030. For more information, visit www.kerry.com.

CONTACT INFORMATION

Investor Relations

Marguerite Larkin, Chief Financial Officer

+353 66 7182292 | investorrelations@kerry.ie

William Lynch, Head of Investor Relations

+353 66 7182292 | investorrelations@kerry.ie

Media

Catherine Keogh, Chief Corporate Affairs & Brand Officer

+353 45 930188 | corpaffairs@kerry.com

Website

www.kerry.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ACQBLBDDDBBDGXD
Date   Source Headline
1st Oct 201811:59 amRNSTotal Voting Rights
1st Oct 201810:39 amRNSDirectorate Change
3rd Sep 20182:25 pmRNSTotal Voting Rights
9th Aug 20183:49 pmRNSTotal Voting Rights
9th Aug 20187:00 amRNSInterim Management Report
2nd Jul 20184:31 pmRNSBlock Listing Six Monthly Return (Schedule 5)
2nd Jul 20184:25 pmRNSTotal Voting Rights
25th Jun 20184:07 pmRNSDirector/PDMR Shareholding
22nd Jun 20183:49 pmRNSNotification of Major Holdings
6th Jun 20187:00 amRNSMain Securities Market Notice
5th Jun 20187:00 amRNSBlock Listing Application
1st Jun 20182:28 pmRNSTotal Voting Rights
29th May 20187:00 amRNSTR-1 Notification of Major Holdings
16th May 20182:50 pmRNSTR-1: Notification of Major Interest in Shares
8th May 20185:44 pmRNSDirectorate Change ? Replacement
8th May 20184:27 pmRNSDirectorate Change
4th May 20189:19 amRNSResult of AGM
3rd May 20183:56 pmRNSDirectorate Change
3rd May 20187:00 amRNSQ1 2018 Interim Management Statement
1st May 20182:47 pmRNSTotal Voting Rights
3rd Apr 201811:42 amRNSTotal Voting Rights
3rd Apr 201810:08 amRNSAnnual Report and AGM Notice
9th Mar 20183:42 pmRNSDirector/PDMR Shareholding
9th Mar 20183:39 pmRNSDirector/PDMR Shareholding
9th Mar 20183:34 pmRNSDirector/PDMR Shareholding
1st Mar 20182:50 pmRNSTotal Voting Rights
20th Feb 20187:00 amRNSPreliminary Statement of Results 31 December 2017
1st Feb 20185:26 pmRNSTotal Voting Rights
22nd Jan 201811:48 amRNSBlock listing Interim Review
3rd Jan 201810:06 amRNSTotal Voting Rights
1st Dec 20174:34 pmRNSTotal Voting Rights
1st Dec 201712:32 pmRNSNotification of Major Holdings
17th Nov 201712:23 pmRNSDirectorate Announcement
14th Nov 20173:58 pmRNSDirector/PDMR Shareholding
8th Nov 20177:00 amRNSQ3 Interim Management Statement
3rd Nov 20173:33 pmRNSTotal Voting Rights
11th Oct 20178:00 amRNSKerry Group Capital Markets Day Update
2nd Oct 20174:43 pmRNSDirectorate Change
2nd Oct 20174:36 pmRNSTotal Voting Rights
6th Sep 20173:41 pmRNSChange to Dividend Currency Option
1st Sep 20174:56 pmRNSTotal Voting Rights
24th Aug 20173:05 pmRNSBlock listing Six Monthly Return
10th Aug 20177:00 amRNSHalf-year Report
1st Aug 201711:54 amRNSTotal Voting Rights
3rd Jul 201710:36 amRNSTotal Voting Rights
2nd Jun 20174:49 pmRNSKerry Group Board Appointments
1st Jun 201711:23 amRNSTotal Voting Rights
11th May 201710:53 amRNSDirector/PDMR Shareholding
9th May 201711:19 amRNSDirectorate Declarations
8th May 20172:09 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.